Cross-disease microbiome signatures can share a technical origin
For a framework predicting generic and disease-specific risk, the reference population and abundance denominator must be defined before cross-disease overlap is interpreted biologically. Extraction blanks, library controls, study batch, sequencing depth, and taxonomic resolution can produce signatures that recur across cohorts. Does the reported cross-talk persist under study-stratified validation, alternative compositional models, and removal of taxa whose prevalence approaches that of negative controls?
